Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults

(2011) I. Salaverria et al.   BLOOD

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era

(2010) Marita Ziepert et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic aberrations in paediatric acute leukaemias and implications for management of patients

(2010) Tomasz Szczepański et al.   LANCET ONCOLOGY

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

(2010) Ryan D Morin et al.   NATURE GENETICS

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

(2009) K. J. Savage et al.   BLOOD

BCL2 expression inde novoDiffuse Large B-cell Lymphoma partly reflects normal differences in age distribution

(2009) Ulf Thunberg et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pediatric follicular lymphoma - a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma - Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials

(2009) I. Oschlies et al.   HAEMATOLOGICA

Immuno–Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study

(2009) Christiane Copie-Bergman et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials

(2008) W. Klapper et al.   BLOOD

Recent advances in the understanding and management of diffuse large B-cell lymphoma in children

(2008) Alfred Reiter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

(2008) D. de Jong et al.   JOURNAL OF CLINICAL PATHOLOGY

Pathway activation patterns in diffuse large B-cell lymphomas

(2008) S Bentink et al.   LEUKEMIA

Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

(2008) W Klapper et al.   LEUKEMIA

Stromal Gene Signatures in Large-B-Cell Lymphomas

(2008) G. Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group

(2008) Rodney R. Miles et al.   PEDIATRIC BLOOD & CANCER

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

(2008) G. Lenz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA